Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer

被引：0
|
作者：
A. Matrone
A. Prete
A. Nervo
A. Ragni
L. Agate
E. Molinaro
C. Giani
L. Valerio
E. Minaldi
A. Piovesan
R. Elisei
机构：
[1] Pisa University Hospital,Department of Clinical and Experimental Medicine, Unit of Endocrinology
[2] Azienda Ospedaliero Universitaria Città Della Salute E Della Scienza Di Torino,Department of Oncology, Oncological Endocrinology Unit
来源：
Journal of Endocrinological Investigation | 2021年 / 44卷
关键词：
Lenvatinib; Medullary thyroid cancer; Calcitonin; Carcinoembrionic antigen; Tyrosine kinase inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2139 / 2151
页数：12
相关论文
共 50 条
  • [1] Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer
    Matrone, A.
    Prete, A.
    Nervo, A.
    Ragni, A.
    Agate, L.
    Molinaro, E.
    Giani, C.
    Valerio, L.
    Minaldi, E.
    Piovesan, A.
    Elisei, R.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (10) : 2139 - 2151
  • [2] Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer
    A. Matrone
    A. Prete
    A. Nervo
    A. Ragni
    L. Agate
    E. Molinaro
    C. Giani
    L. Valerio
    E. Minaldi
    A. Piovesan
    R. Elisei
    Journal of Endocrinological Investigation, 2021, 44 : 2859 - 2859
  • [3] Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer
    Iniguez-Ariza, Nicole M.
    Ryder, Mabel M.
    Hilger, Crystal R.
    Bible, Keith C.
    THYROID, 2017, 27 (07) : 923 - 927
  • [4] Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer (Feb, 10.1007/s40618-020-01491-3, 2021)
    Matrone, A.
    Prete, A.
    Nervo, A.
    Ragni, A.
    Agate, L.
    Molinaro, E.
    Giani, C.
    Valerio, L.
    Minaldi, E.
    Piovesan, A.
    Elisei, R.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (12) : 2859 - 2859
  • [5] Vandetanib: A novel targeted therapy for the treatment of metastatic or locally advanced medullary thyroid cancer
    Ton, GiangThy N.
    Banaszynski, Megan E.
    Kolesar, Jill M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (10) : 849 - 855
  • [6] Positive results with lenvatinib for the treatment of advanced medullary thyroid cancer in a phase II trial
    Nature Reviews Endocrinology, 2015, 11 (11) : 632 - 632
  • [7] A Case of Lenvatinib-Induced Focal Segmental Glomerulosclerosis (FSGS) in Metastatic Medullary Thyroid Cancer
    Fleming, Kathryn
    McGuinness, James
    Kipgen, David
    Glen, Hilary
    Spiliopoulou, Pavlina
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2018, 2018
  • [8] Personalized cancer therapy for patients with metastatic medullary thyroid cancer (MTC).
    Misiukiewicz, Krzysztof
    Winder, Lewis
    Posner, Marshall R.
    Genden, Eric Michael
    Zhang, David Y.
    Cagan, Ross L.
    Donovan, Michael J.
    Schadt, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Medullary thyroid cancer: Options for systemic therapy of metastatic disease?
    Martins, RG
    Rajendran, JG
    Capell, P
    Byrd, DR
    Mankoff, DA
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (11) : 1653 - 1655
  • [10] Lenvatinib acts as the salvage therapy for advanced hepatocellular carcinoma
    Hsieh, M-C.
    Su, Y-L.
    Chen, Y-Y.
    Liu, C-T.
    Chen, Y-H.
    Chiu, T-J.
    Pei, S-N.
    Wu, C-C.
    Rau, K-M.
    ANNALS OF ONCOLOGY, 2018, 29 : 57 - 57
12345